Found 0 matching trials
Gene Therapy Trial for Platelet Derived Factor VIII Production in Hemophilia A PHASE1 This is a Phase I study. This research study is being conducted to find new...
Show More Status
Active Not Recruiting
Location
Froedtert Hospital and the Medical College of Wisconsin
Learn More & Join Trial
Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia PHASE3 The primary objective of this study is to demonstrate the efficacy of Iomab...
Show More Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
Study of OFATUMUMAB as Part of the Scheme of Reduced Intensity Conditioning in High Risk Non-Hodgkin Lymphoma B Patients PHASE2 The aim of this study is rate of acute graft-versus-host disease II-IV meas...
Show More Location
Hospital Vall d'Hebron
Learn More & Join Trial
Pilot Study of Reduced Intensity Haematopoietic Stem Cell Transplantation in Patients With Poor Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML) Utilising Conditioning With Fludarabine, Busulphan and Thymoglobulin PHASE2 The purpose of this study is to determine the safety and feasibility of con...
Show More Location
King's College Hospital NHS Foundation Trust
Learn More & Join Trial
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC) NA This is a treatment guideline for a second or greater allogeneic hematopoie...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial
URMC Related Haplo-identical Donor BMT PHASE1 This study will be a single-center treatment protocol, designed to validate...
Show More Location
Wilmot Cancer Institute
Learn More & Join Trial
Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN PHASE1 This clinical trial involves individuals who have been diagnosed with Acute...
Show More Status
Active Not Recruiting
Location
Dana-Farber Cancer Institute
Learn More & Join Trial
Blinatumomab After TCR Alpha Beta/CD19 Depleted HCT PHASE2 This trial will assess the feasibility of alpha/beta T-cell and B-cell depl...
Show More Location
Children's Hospital of Wisconsin
Learn More & Join Trial
Enhancing Graft vs Leukemia Via Delayed Ex-Vivo Co-Stimulated DLI After Non-Myeloablative Stem Cell Transplantation PHASE1 This is a new platform in non-myeloablative allogeneic stem cell transplant...
Show More Location
Abramson Cancer Center at University of Pennsylvania
Learn More & Join Trial
Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation PHASE2 This randomized phase II trial includes a blood stem cell transplant from a...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial